S264: PRELIMINARY ANALYSES OF A NON-GENE-EDITING ALLOGENTIC CAR-T IN CD19+ RELAPSED OR REFRACTORY NON-HODGIN’S LYMPHOMA

• X. Wang,
• L. Xue,
• S. Li,
• Q. Fan,
• K. Liu,
• R. Jin,
• X. Yang,
• T. Wang,
• L. He,
• J. Li

Affiliations

X. Wang

1 Department of Hematology, The First Affiliated Hospital of USTC, Hefei

L. Xue

1 Department of Hematology, The First Affiliated Hospital of USTC, Hefei

S. Li

1 Department of Hematology, The First Affiliated Hospital of USTC, Hefei

Q. Fan

1 Department of Hematology, The First Affiliated Hospital of USTC, Hefei

K. Liu

2 Fundamenta Therapeutics Inc., Suzhou, China

R. Jin

2 Fundamenta Therapeutics Inc., Suzhou, China

X. Yang

1 Department of Hematology, The First Affiliated Hospital of USTC, Hefei

T. Wang

2 Fundamenta Therapeutics Inc., Suzhou, China

L. He

2 Fundamenta Therapeutics Inc., Suzhou, China

J. Li

2 Fundamenta Therapeutics Inc., Suzhou, China